Matthew McCord

ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

Víctor A. Arrieta, Andrew Chen, J. Robert Kane et al. · Nature Cancer · 2021 · 120 citations · Full text

Medicine, Cancer Biology, Oncology +16

Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas

Michael Drumm, Karan Dixit, Sean Grimm et al. · Neuro-Oncology · 2019 · 102 citations · Full text

Medicine, Neurology, Oncology +14

Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas

Víctor A. Arrieta, Andrew Gould, Karl J. Habashy et al. · Nature Communications · 2024 · 92 citations · Full text

Medicine, Oncology, Pharmacology +17

Neuropathology of Anti-Amyloid-β Immunotherapy: A Case Report

Rudolph J. Castellani, Elisheva D. Shanes, Matthew McCord et al. · Journal of Alzheimer s Disease · 2023 · 90 citations

Medicine, Neurology, Pathology +17

High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13

Drew Pratt, Zied Abdullaev, Antonios Papanicolau‐Sengos et al. · Acta Neuropathologica · 2022 · 57 citations · Full text

Medicine, Oncology, Pathology +15